0001209191-23-022421.txt : 20230403 0001209191-23-022421.hdr.sgml : 20230403 20230403200013 ACCESSION NUMBER: 0001209191-23-022421 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230403 DATE AS OF CHANGE: 20230403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Puttagunta Sailaja CENTRAL INDEX KEY: 0001792314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38503 FILM NUMBER: 23794668 MAIL ADDRESS: STREET 1: C/O BIOMX LTD. STREET 2: 7 PINHAS SAPIR ST., FLOOR 2 CITY: NESS ZIONA STATE: L3 ZIP: 7414002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Iterum Therapeutics plc CENTRAL INDEX KEY: 0001659323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: FITZWILLIAM COURT, 1ST FLOOR STREET 2: LEESON CLOSE CITY: DUBLIN 2 STATE: L2 ZIP: D02 YW24 BUSINESS PHONE: (872) 225-6077 MAIL ADDRESS: STREET 1: FITZWILLIAM COURT, 1ST FLOOR STREET 2: LEESON CLOSE CITY: DUBLIN 2 STATE: L2 ZIP: D02 YW24 FORMER COMPANY: FORMER CONFORMED NAME: Iterum Therapeutics Ltd DATE OF NAME CHANGE: 20151124 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-31 0 0001659323 Iterum Therapeutics plc ITRM 0001792314 Puttagunta Sailaja C/O ITERUM THERAPEUTICS PLC FITZWILLIAM COURT, FL. 1, LEESON CLOSE DUBLIN 2 L2 IRELAND 0 1 0 0 Chief Medical Officer 0 Stock Option (Right to Buy) 1.00 2023-03-31 4 A 0 75000 0.00 A 2033-03-30 Ordinary Shares 75000 75000 D The shares underlying this option shall vest at a rate of 33.3% of the total number of shares on the one-year anniversary of March 31, 2023 and the remaining 66.7% will vest in equal monthly installments thereafter until March 31, 2026, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date. /s/ Sailaja Puttagunta 2023-04-03